Skip to main content
Clinitech Laboratory Limited logo

Clinitech Laboratory Limited — Investor Relations & Filings

Ticker · 544220 ISIN · INE0QMR01015 BSE.NS Human health and social work activities
Open in API
Filings indexed 4 across all filing types
Latest filing 2026-05-28 Regulatory Filings
Country IN India
Listing BSE.NS 544220

About Clinitech Laboratory Limited

https://ctllab.in/

Clinitech Laboratory Limited is a diagnostic service provider specializing in pathology and clinical laboratory medicine. The organization offers a comprehensive suite of diagnostic services, including biochemistry, hematology, immunology, microbiology, and molecular biology. It provides a wide array of health check-up packages and specialized testing for chronic disease management, oncology, and infectious diseases. Utilizing automated diagnostic platforms and advanced laboratory technology, the company focuses on delivering accurate and timely clinical results. Key service offerings include home sample collection, corporate wellness programs, and diagnostic support for hospitals and clinics. The laboratory adheres to international quality standards and rigorous internal quality control protocols to ensure precision in medical diagnostics.

Recent filings

Filing Released Lang Actions
Statement disclosing no deviation and Variation from object of issue as on March 31, 2026
Regulatory Filings Classification · 90% confidence The document is a compliance disclosure under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) — a statement of deviation/variation in use of IPO proceeds filed with the stock exchange. It is not an earnings release or full financial report but a routine regulatory filing of compliance information. Therefore it falls under Regulatory Filings (RNS).
2026-05-28 English
Outcome of Board meeting held today i.e May 28, 2026 through video conferencing at 02.30 P.M for approval of Audited Financial Results for the half year and financial year ended March 31, 2026
Interim / Quarterly Report Classification · 87% confidence The document is the notification of the Board Meeting outcome under SEBI Regulation 33, approving and attaching the audited standalone & consolidated financial results (including full balance sheet, auditor’s report, and notes) for the half year and financial year ended March 31, 2026. It contains substantive interim-period financial statements (half‐year) and is not a short “attached report” announcement (RPA) nor the full company annual report (10‐K), but a detailed, periodical financial results release. This matches the definition of an Interim / Quarterly Report (IR). FY 2026
2026-05-28 English
With reference to the above captioned subject, we wish to intimate your esteemed exchange that as decided in the Meeting of the Board of Directors of the Company held today, i.e., on May, ....
Interim / Quarterly Report Classification · 85% confidence The document is an exchange filing under SEBI Regulation 33 announcing and enclosing the Audited Standalone and Consolidated Financial Results for the half‐year and year ended March 31, 2026, together with the full financial statements (balance sheet, auditor’s report, etc.). It is a comprehensive periodic financial report for a period shorter than (and including) the fiscal year’s interim period, not merely a press‐style earnings summary. Hence it is classified as an Interim/Quarterly Report (IR). FY 2026
2026-05-28 English
Clinitech Laboratory Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve To consider and approve ....
Regulatory Filings Classification · 98% confidence The document is a formal notice to BSE of an upcoming Board of Directors meeting to approve audited financial statements and other agenda items, filed under SEBI LODR Regulations. It is not reporting management changes (no appointments or resignations), not publishing a report itself, nor providing the actual financial results. It is a routine regulatory announcement of a board meeting. Therefore, it falls under the “Regulatory Filings” category (general regulatory announcements).
2026-05-22 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.